Buscar
Applied DNA Sciences Inc
APDNAñadir a la lista de seguimiento
5.620USD
0.0000.00%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
2.59MCap. mercado
PérdidaP/E TTM
Más Datos de Applied DNA Sciences Inc Compañía
Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
Información de Applied DNA Sciences Inc
Símbolo de cotizaciónAPDN
Nombre de la empresaBNB Plus Corp
Fecha de salida a bolsaAug 24, 2001
Director ejecutivoShorrock (Clay)
Número de empleados46
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 24
Dirección50 Health Sciences Drive
CiudadSTONY BROOK
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal11790
Teléfono16312408800
Sitio Webhttps://adnas.com/
Símbolo de cotizaciónAPDN
Fecha de salida a bolsaAug 24, 2001
Director ejecutivoShorrock (Clay)
Ejecutivos de Applied DNA Sciences Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joshua (Josh) Kruger
Mr. Joshua (Josh) Kruger
Chairman of the Board
Chairman of the Board
150.60K
+50.00%
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
75.30K
+75.17%
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
22.52K
+0.01%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
22.51K
--
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
22.51K
-0.00%
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
Chief Executive Officer
Chief Executive Officer
12.62K
-48.20%
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
10.21K
-83.06%
Ms. Elizabeth M. Schmalz Shaheen
Ms. Elizabeth M. Schmalz Shaheen
Independent Director
Independent Director
--
--
Mr. Sanjay M. Hurry
Mr. Sanjay M. Hurry
Executive Director - Investor Relations and Corporate Communications
Executive Director - Investor Relations and Corporate Communications
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joshua (Josh) Kruger
Mr. Joshua (Josh) Kruger
Chairman of the Board
Chairman of the Board
150.60K
+50.00%
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
75.30K
+75.17%
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
22.52K
+0.01%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
22.51K
--
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
22.51K
-0.00%
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
Chief Executive Officer
Chief Executive Officer
12.62K
-48.20%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Applied DNA Sciences Inc?
Los cinco principales accionistas de Applied DNA Sciences Inc son: Mr. Joshua (Josh) Kruger
¿Cuántas instituciones poseen acciones de Applied DNA Sciences Inc (APDN)?
A fecha de 2026Q1, 63 instituciones poseen acciones de Applied DNA Sciences Inc, con un valor de mercado combinado de aproximadamente 115.59K, lo que representa el 2.04% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 21093.00.
¿Cuál es la mayor fuente de ganancias de Applied DNA Sciences Inc?
El 2026Q1, el segmento empresarial Product and authentication services - Large scale DNA production generó la ganancia más alta para Applied DNA Sciences Inc, ascendiendo a 423.01K y representando el 74.82% de la ganancia total.